A recent clinical trial, published on May 14, 2026, suggests that daily multivitamin-mineral supplementation may play a role in slowing the process of biological aging in older adults. The study, conducted by researchers at Columbia University and Brigham and Women's Hospital, involved over 5,000 participants aged 65 and older.
The trial, a randomized, double-blind, placebo-controlled study, assessed the effects of a daily multivitamin on various markers of biological aging. Researchers utilized epigenetic clocks, which are molecular tools that estimate an individual's biological age based on DNA methylation patterns, to measure changes over a two-year period. The findings indicated that participants who took a daily multivitamin experienced a modestly slower rate of biological aging compared to those in the placebo group. Specifically, the multivitamin group showed a statistically significant reduction in the pace of epigenetic aging by approximately 2% over the study duration.
While the observed effect was small, the study's large sample size and rigorous design lend weight to its conclusions. The researchers emphasized that these findings do not suggest a cure for aging, but rather a potential strategy to support healthy aging through nutritional supplementation. The multivitamins used in the study contained a comprehensive blend of vitamins and minerals, addressing potential micronutrient deficiencies common in older populations. Further research is needed to understand the long-term implications and the specific mechanisms through which multivitamins might influence biological aging.
This research builds upon previous studies exploring the link between nutrition and longevity. While a balanced diet rich in fruits, vegetables, and whole grains remains paramount for overall health, the study suggests that a daily multivitamin could offer additional support for cellular health in older adults. Consumers are advised to consult with healthcare professionals before starting any new supplement regimen.